Publications by authors named "Sujun Gao"

Claim this Profile
S
Safety assessment of ustekinumab in inflammatory bowel disease: a real-world analysis based on the FDA adverse event reporting system (FAERS).
Likang Xu, Zhenkai Huang, Gong Chen, Chao Sun, Yang Yu, Sujun Gao

Eur J Med Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes between haploidentical and matched related donors for chronic myelomonocytic leukemia: A multicenter real-world study.
Yu-Qian Sun, Li-Xin Wu, Yi-Cheng Zhang, Ya-Jing Xu, Xiao-Bing Huang, Su-Jun Gao

Int J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A first-in-class JAK/ROCK inhibitor, Rovadicitinib in patients with myelofibrosis who were refractory or relapsed or intolerant to Ruxolitinib: A single-arm, multicenter, open-label, phase Ib study.
Minghua Hong, Dawei Ding, Min Zhang, Sujun Gao, Luxi Song

Eur J Pharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, mortality, and survival associated with acute leukaemia subtypes by age group in China: a population-based cancer registry analysis and cohort study.
Wei Yin, Xiaoyu Yan, Jiaoyang Cai, Bingfeng Han, Peng Yin, Sujun Gao, Ju Gao

Lancet Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of mitoxantrone hydrochloride liposome containing regimens in acute myeloid leukemia.
Tie-Jun Gong, Wei-Ming Li, Li Liu, Yu-Qing Chen, Su-Jun Gao

Oncologist· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Luteolin as a multifaceted immunomodulator: insights into its effects on diverse immune cell populations and therapeutic implications.
Xiaolan Wang, Junbo Zhao, Ying Li, Sujun Gao, Long Su

Front Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Internal tandem duplications of FLT3 containing exogenous sequences are associated with poor clinical outcomes in acute myeloid leukemia.
Shao-Tong Li, Xiu-Min Shi, Qiu-Ju Liu, Ye-Hui Tan, Hai Lin, Su-Jun Gao

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of FLT3 mutation on its intracellular localization and implications for anti-leukemia strategy.
Fei Song, Long Su, Sujun Gao

Ann Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematological malignancy burden in mainland China and Taiwan from 1990 to 2021 and decadal projections: Insights from the global burden of disease study 2021.
Yu Fu, Ya-Zhe Du, Yun-Wei Zhang, Fei Song, Su-Jun Gao

PLoS One· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The global academic distribution and changes in research hotspots of artificial intelligence in inflammatory bowel disease since 2000.
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A higher ratio of IL-2/IL-4 may be an early predictor of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Yu Fu, Meifang Zhao, Xiaoliang Liu, Sujun Gao, Yehui Tan

Front Immunol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes in Philadelphia chromosome-positive acute lymphoblastic leukemia patients treated with ponatinib or imatinib: results from the PhALLCON trial.
Ajibade Ashaye, Ling Shi, Ibrahim Aldoss, Pau Montesinos, Pankit Vachhani, Sujun Gao

Leukemia· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect Comparisons of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with R/R MCL: An Extended Follow-up Analysis.
Lijuan Deng, Yuqin Song, Keshu Zhou, Dengju Li, Jianda Hu, Sujun Gao

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical evaluation of personalized treatment guided by PCR detection from fecal samples: a real-world study.
Ruolin Peng, Zhimei Zhang, Chuchu Yang, Zhengyuan Xu, Jiabin Wang, Sujun Gao

Front Cell Infect Microbiol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, efficacy, and safety of subcutaneous versus intravenous rituximab in previously untreated Chinese patients with CD20+ diffuse large B-cell lymphoma: a phase II randomized controlled trial.
Yan Gao, Liling Zhang, Sujun Gao, Yu Yang, Qingyuan Zhang

Leuk Lymphoma· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death with cerebral infarction in a patient with VEXAS syndrome.
Zhenzhen Han, Hongqiong Fan, Qiang Guo, Yajuan Li, Siwen Liu, Sujun Gao

Rheumatology (Oxford)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multifactorial risk scoring system for the prediction of early relapse in CMML patients with allo-HSCT: a nationwide representative multicenter study.
Jian-Ying Zhou, Yu-Xiu Chen, Hai-Long Yuan, Ya-Jing Xu, Xiao-Bing Huang, Su-Jun Gao

Bone Marrow Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of allogeneic hematopoietic stem cell transplantation versus intensive chemotherapy in patients with myeloid sarcoma: a nationwide representative multicenter study.
Jie Sun, Yi-Cheng Zhang, Jia Wei, Ya-Jing Xu, Yue Zhang, Su-Jun Gao

Bone Marrow Transplant· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of gecacitinib vs hydroxyurea in patients with intermediate-2 or high-risk myelofibrosis: final analysis results from a randomized phase 3 study.
Yi Zhang, Hu Zhou, Shanshan Suo, Junling Zhuang, Linhua Yang, Sujun Gao

Blood Cancer J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ruxolitinib plus steroids for acute graft versus host disease: a multicenter, randomized, phase 3 trial.
Liping Dou, Yanli Zhao, Jingjing Yang, Lei Deng, Nan Wang, Sujun Gao

Signal Transduct Target Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worldwide research trends in Crohn's disease treatment over the past 2 decades: a bibliometric analysis.
Likang Xu, Jinzhao Zou, Chao Sun, Gong Chen, Sujun Gao

Front Pharmacol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of zuberitamab plus CHOP versus rituximab plus CHOP for the treatment of drug-naïve patients diagnosed with CD20-positive diffuse large B-cell lymphoma: a phase 3 trial.
Zhiming Li, Wenqi Jiang, Hui Zhou, Hong Cen, Mingzhi Zhang, Sujun Gao

J Immunother Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Icariin protects against acute graft-versus-host disease while preserving graft-versus-leukemia activity after allogeneic hematopoietic stem cell transplantation.
Long Su, Zhi-Feng Wei, Chen-Chen Pi, Tian-Xue Qin, Fei Song, Su-Jun Gao

Phytomedicine· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The molecular effects underlying the pharmacological activities of daphnetin.
Zhifeng Wei, Na Wei, Long Su, Sujun Gao

Front Pharmacol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel HLA-C allele, HLA-C*02:246.
Xiu-Min Shi, Su-Jun Gao

HLA· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis